Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Nicoli

Showing results (11-20 of 50) with videos related to

Pageof 5
Sort By:
European Journal of Public Health|January 17, 2021
Public support for European cooperation in the procurement, stockpiling and distribution of medicinesRoel Beetsma, Brian Burgoon, Francesco Nicoli, et al.
Scientific Reports|July 17, 2020
The TLR9 ligand CpG ODN 2006 is a poor adjuvant for the induction of de novo CD8<sup>+</sup> T-cell responses in vitroLaura Papagno, Nozomi Kuse, Anna Lissina, et al.
High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension|June 14, 2017
Long-term Saxagliptin Treatment Improves Endothelial Function but not Pulse Wave Velocity and Intima-Media Thickness in Type 2 Diabetic PatientsRaffaella Dell'Oro, Alessandro Maloberti, Francesco Nicoli, et al.
Molecules (Basel, Switzerland)|January 8, 2023
Design, Synthesis and Evaluation of New Multifunctional Benzothiazoles as Photoprotective, Antioxidant and Antiproliferative AgentsRiccardo Barbari, Chiara Tupini, Elisa Durini, et al.
Geroscience|June 26, 2020
Age-related decline of de novo T cell responsiveness as a cause of COVID-19 severityFrancesco Nicoli, Maria Teresa Solis-Soto, Deepak Paudel, et al.
Frontiers in Cellular and Infection Microbiology|July 2, 2019
In Chronic Hepatitis C Infection, Myeloid-Derived Suppressor Cell Accumulation and T Cell Dysfunctions Revert Partially and Late After Successful Direct-Acting Antiviral TreatmentValentina Telatin, Francesco Nicoli, Chiara Frasson, et al.
Human Vaccines & Immunotherapeutics|April 16, 2015
Effects of different routes of administration on the immunogenicity of the Tat protein and a Tat-derived peptideValentina Finessi, Francesco Nicoli, Eleonora Gallerani, et al.
Geroscience|November 22, 2022
Focus group study on perceptions and information needs regarding vaccines targeting the older population: a cross-country comparison in four European countriesManuela Dominique Wennekes, Renske Eilers, Antonella Caputo, et al.
Frontiers in Cellular and Infection Microbiology|December 3, 2021
Altered Lipid Profiles and Vaccine Induced-Humoral Responses in Children Living With HIV on Antiretroviral Therapy in TanzaniaWilbert Mbuya, Issakwisa Mwakyula, Willyelimina Olomi, et al.
Vaccines|June 10, 2020
The Tat Protein of HIV-1 Prevents the Loss of HSV-Specific Memory Adaptive Responses and Favors the Control of Viral ReactivationFrancesco Nicoli, Eleonora Gallerani, Mariaconcetta Sicurella, et al.
Pageof 5

Showing results (11-20 of 50) with videos related to

Sort By:
Pageof 5
European Journal of Public Health|January 17, 2021
Public support for European cooperation in the procurement, stockpiling and distribution of medicinesRoel Beetsma, Brian Burgoon, Francesco Nicoli, et al.
Scientific Reports|July 17, 2020
The TLR9 ligand CpG ODN 2006 is a poor adjuvant for the induction of de novo CD8<sup>+</sup> T-cell responses in vitroLaura Papagno, Nozomi Kuse, Anna Lissina, et al.
High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension|June 14, 2017
Long-term Saxagliptin Treatment Improves Endothelial Function but not Pulse Wave Velocity and Intima-Media Thickness in Type 2 Diabetic PatientsRaffaella Dell'Oro, Alessandro Maloberti, Francesco Nicoli, et al.
Molecules (Basel, Switzerland)|January 8, 2023
Design, Synthesis and Evaluation of New Multifunctional Benzothiazoles as Photoprotective, Antioxidant and Antiproliferative AgentsRiccardo Barbari, Chiara Tupini, Elisa Durini, et al.
Geroscience|June 26, 2020
Age-related decline of de novo T cell responsiveness as a cause of COVID-19 severityFrancesco Nicoli, Maria Teresa Solis-Soto, Deepak Paudel, et al.
Frontiers in Cellular and Infection Microbiology|July 2, 2019
In Chronic Hepatitis C Infection, Myeloid-Derived Suppressor Cell Accumulation and T Cell Dysfunctions Revert Partially and Late After Successful Direct-Acting Antiviral TreatmentValentina Telatin, Francesco Nicoli, Chiara Frasson, et al.
Human Vaccines & Immunotherapeutics|April 16, 2015
Effects of different routes of administration on the immunogenicity of the Tat protein and a Tat-derived peptideValentina Finessi, Francesco Nicoli, Eleonora Gallerani, et al.
Geroscience|November 22, 2022
Focus group study on perceptions and information needs regarding vaccines targeting the older population: a cross-country comparison in four European countriesManuela Dominique Wennekes, Renske Eilers, Antonella Caputo, et al.
Frontiers in Cellular and Infection Microbiology|December 3, 2021
Altered Lipid Profiles and Vaccine Induced-Humoral Responses in Children Living With HIV on Antiretroviral Therapy in TanzaniaWilbert Mbuya, Issakwisa Mwakyula, Willyelimina Olomi, et al.
Vaccines|June 10, 2020
The Tat Protein of HIV-1 Prevents the Loss of HSV-Specific Memory Adaptive Responses and Favors the Control of Viral ReactivationFrancesco Nicoli, Eleonora Gallerani, Mariaconcetta Sicurella, et al.
Pageof 5